Depression during the COVID-19 pandemic (analysis of clinical cases)

@article{Dorozhenok2021DepressionDT,
  title={Depression during the COVID-19 pandemic (analysis of clinical cases)},
  author={Igor Yu. Dorozhenok},
  journal={Neurology, neuropsychiatry, Psychosomatics},
  year={2021},
  volume={13},
  pages={81-86}
}
  • I. Y. Dorozhenok
  • Published 17 February 2021
  • Psychology, Medicine
  • Neurology, neuropsychiatry, Psychosomatics
Currently, in various world regions, the prevalence of depressive and anxiety disorders due to the impact of coronavirus infection is repeatedly increased compared to that in previous years. Among the predictors of their development during the pandemic, there are COVID-19 symptoms, a history of mental disorders, as well as restrictive measures, and financial losses. The paper describes three clinical cases of depressive disorders during the COVID-19 pandemic, with the depiction of the anamnesis… 
DEPRESSION IN CANCER PATIENTS DURING COVID-19 PANDEMIC
TLDR
The WHO European Regional Office considers this period to be the tipping point of the pandemic, linking it to the beginning of mass vaccination and the accumulated experience in the diagnosis and treatment of COVID-19 and its consequences.
Post-covid-19 neurological syndromes
TLDR
The article highlights the pathogenesis, clinical manifestations of lesions of the central and peripheral nervous system that have arisen or persist in patients in the postcoid period (Long-COVID-19) to prevent the progression of cognitive, emotional, behavioral disorders initiated by SARS-CoV-2.
The method of inhalation therapy with micro-doses of mixtures noble gases with oxygen
TLDR
A device that allows dosed injection of noble gas with a volume of about 2-4 ml with peroxide vapors into the nasal cavity is designed and a positive effect from 18 people is noted.